Q2 25 EPS
$1.89
MISS 0.29%
Est. $1.90
Q2 25 Revenue
$4.03B
MISS 0.17%
Est. $4.03B
vs S&P Since Q2 25
-13.0%
TRAILING MARKET
ECL +0.6% vs S&P +13.6%
Market Reaction
Did ECL Beat Earnings? Q2 2025 Results
Ecolab posted a narrow earnings miss in Q2 2025, with adjusted diluted EPS of $1.89 falling just short of the $1.90 consensus estimate by 0.29%, even as the company delivered 13% year-over-year EPS growth fueled by value pricing, volume gains, and pr… Read more Ecolab posted a narrow earnings miss in Q2 2025, with adjusted diluted EPS of $1.89 falling just short of the $1.90 consensus estimate by 0.29%, even as the company delivered 13% year-over-year EPS growth fueled by value pricing, volume gains, and productivity improvements. Revenue of $4.03 billion came in 0.17% below estimates and grew just 1.0% year over year, with a 2% drag from the prior-year divestiture of its global surgical solutions business masking underlying organic sales growth of 3%. The single most compelling story of the quarter was the momentum in Ecolab's designated growth engines, particularly Global High-Tech, where innovative cooling technologies for data centers and AI infrastructure drove strong double-digit gains, a trend the company is doubling down on with its announced $1.8 billion acquisition of Ovivo's electronics unit to expand its ultra-pure water capabilities for semiconductor manufacturing. Looking ahead, Ecolab maintained its full-year 2025 adjusted diluted EPS outlook of $7.42 to $7.62, representing 12% to 15% growth, and guided Q3 2025 EPS to $2.02 to $2.12.
Key Takeaways
- • Value pricing contributed 2% to organic sales growth
- • Volume growth of 1% driven by new business wins and breakthrough innovation
- • Productivity improvements and SG&A leverage enabled by digital capabilities
- • One Ecolab enterprise selling strategy driving share gains across segments
- • Growth engines (Life Sciences, Pest Elimination, Global High-Tech, Ecolab Digital) collectively grew sales double digits
- • Lower supply chain costs in Institutional & Specialty and Life Sciences segments
ECL YoY Financials
Q2 2025 vs Q2 2024, source: SEC Filings
ECL Revenue by Segment
With YoY comparisons, source: SEC Filings
“The Ecolab team executed very well to deliver another strong quarter of double-digit earnings growth. Our Institutional & Specialty and Global Water segments delivered solid growth, outperforming end-market trends as we benefited from share gains supported by the One Ecolab growth strategy, breakthrough innovation, and strong value pricing. Our growth engines, which include Life Sciences, Pest Elimination, Global High-Tech and Ecolab Digital, collectively grew sales double digits, with very strong operating income growth. All of this, combined with SG&A leverage enabled by our digital capabilities, drove continued robust operating income margin expansion.”
— Christophe Beck, Q2 2025 Earnings Press Release
ECL Earnings Trends
ECL vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
ECL EPS Trend
Earnings per share: estimate vs actual
ECL Revenue Trend
Quarterly revenue: estimate vs actual
ECL Quarterly Results
5 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q1 26 BEAT | $1.70 | $1.70 | +0.15% | $4.07B | +0.93% |
| Q4 25 BEAT FY | $2.07 | $2.08 | +0.48% | $4.20B | +0.56% |
| FY Full Year | $7.53 | $7.53 | +0.00% | $16.08B | +0.14% |
| Q3 25 MISS | $2.07 | $2.07 | -0.09% | $4.17B | +1.07% |
| Q2 25 MISS | $1.90 | $1.89 | -0.29% | $4.03B | -0.17% |
| Q1 25 BEAT | $1.50 | $1.50 | +0.05% | $3.70B | -0.02% |